HLS Therapeutics Inc. Opens the Market
March 16 2018 - 11:00AM
PR Newswire (Canada)
TORONTO, March 16, 2018 /CNW/ - Bill Wells, Executive Chairman of the Board, HLS
Therapeutics Inc. (HLS), joined Tim
Babcock, Director, Listed Issuer Services, TSX Venture
Exchange, to open the market. HLS Therapeutics Inc. is a specialty
pharmaceutical company focused on the acquisition and
commercialization of late stage development, commercial stage
promoted and established stage branded pharmaceutical products in
the North American markets. HLS Therapeutics Inc. commenced trading
on TSX Venture Exchange on March 14,
2018.
SOURCE TMX Group Limited
Copyright 2018 Canada NewsWire
Hls Therapeutics (TSXV:HLS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Hls Therapeutics (TSXV:HLS)
Historical Stock Chart
From Aug 2023 to Aug 2024